Hyderabad based drug maker Dr Reddy’s Laboratories has acquired Habitrol brand, a nicotine replacement therapy transdermal patch, from Novartis Consumer Health Inc. The acquisition of Habitrol brand from Novartis Consumer Health Inc was done following issuance of the proposed consent order from the US Federal Trade Commission on November 26.

Leave your comment

*

code